ALLN hinders HCT116 tumor growth through Bax-dependent apoptosis

Biochemical and Biophysical Research Communications

Volumn 437, Issue 2, 2013, Pages 325-330

  Li, Shang ze ^a   Zhang, Hui hui ^a   Zhang, Jia nong ^a   Zhang, Ze yan ^a   Zhang, Xiao fei ^a   Zhang, Xiao dong ^a   Du, Run lei ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

ALLN; Anti tumor; Apoptosis; Bax; Colon cancer; Mitochondria

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; N ACETYLLEU LEUNORLEUCINAL; PROTEIN BAX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL STRAIN HCT116; CELL VIABILITY; COLON CANCER; CYTOSOL; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ALLN; ANTI-TUMOR; APOPTOSIS; BAX; CCK-8; CELL COUNTING KIT-8; COLON CANCER; MITOCHONDRIA; N-ACETYL-LEU-LEUNORLEUCINAL; PBS; PHOSPHATE-BUFFERED SALINE; POLYVINYLIDENE DIFLUORIDE; PVDF;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; CELL LINE, TUMOR; HUMANS; LEUPEPTINS;

MUS MUSCULUS;

EID: 84880716445     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.088     Document Type: Article

References (24)

1. Siegel R., Naishadham A., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012, 62:10-29.
2. Kan W.L.T., Yin C., Xu H.X., Xu G., To K.K.W., Cho C.H., Rudd J.A., Lin G. Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G0/G1 cell cycle arrest and apoptosis. Int. J. Cancer 2013, 132:707-716.
3. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348.
4. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997, 275:967-969.
5. Zhang L., Yu J., Park B.H., Kinzler K.W., Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000, 290:989-992.
6. Haneef J., Parvathy M., Thankayyan R.S., Sithul H., Sreeharshan S. Bax translocation mediated mitochondrial apoptosis and caspase dependent photosensitizing effect of Ficus religiosa on cancer cells. PLoS ONE 2012, 7:e40055.
7. Zhu S., Li T., Tan J., Yan X., Zhang D., Zheng C., Chen Y., Xiang Z., Cui H. Bax is essential for death receptor-mediated apoptosis in human colon cancer cells. Cancer Biother. Radiopharm. 2012, 27:577-581.
8. McCurrach M.E., Connor T.M., Knudson C.M., Korsmeyer S.J., Lowe S.W. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 1997, 94:2345-2349.
9. Chandrika B.B., Maney S.K., Lekshmi S.U., Joseph J., Seervi M., et al. Bax deficiency mediated drug resistance can be reversed by endoplasmic reticulum stress induced death signaling. Biochem. Pharmacol. 2010, 79:1589-1599.
10. Goll D.E., Thompson V.F., Li H., Wei W., Cong J. The calpain system. Physiol. Rev. 2003, 83:731-801.
11. Storr S.J., Carragher N.O., Frame M.C., Parr T., Martin S.G. The calpain system and cancer. Nat. Rev. Cancer 2011, 11:364-374.
12. Atencio I.A., Ramachandra M., Shabram P., Demers G.W. Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ. 2000, 11:247-253.
13. An W.G., Hwang S.G., Trepel J.B., Blagosklonny M.V. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia 2000, 14:1276-1283.
14. Haneef J., Parvathy M., Thankayyan R.S., Sithul H., Sreeharshan S. Bax translocation mediated mitochondrial apoptosis and caspase dependent photosensitizing effect of Ficus religiosa on cancer cells. PLoS ONE 2012, 7:e40055.
15. Cheung A.M., Hande M.P., Jalali F., Tsao M.S., Skinnider B., Hirao A., McPherson J.P., Karaskova J., Suzuki A., Wakeham A., You-Ten A., Elia A., Squire J., Bristow R., Hakem R., Mak T.W. Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cancer Res. 2002, 62:6194-6204.
16. Blankenberg F.G. Apoptosis imaging: anti-cancer agents in medicinal chemistry. Anticancer Agents Med. Chem. 2009, 9:944-951.
17. Croker B.A., O'Donnell J.A., Nowell C.J., Metcalf D., Dewson G., Campbell K.J., Rogers K.L., Hu Y., Smyth G.K., Zhang J.G., White M., Lackovic K., Cengia L.H., O'Reilly L.A., Bouillet P., Cory S., Strasser A., Roberts A.W. Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1. Proc. Natl. Acad. Sci. USA 2011, 108:13135-13140.
18. Xu L., Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J. Biol. Chem. 2006, 281:35567-35575.
19. Guicciardi M.E., Gores G.J. Calpains can do it alone: implications for cancer therapy. Cancer Biol. Ther. 2003, 2:153-154.
20. Lim do Y., Park J.H. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G1060-G1068.
21. Srivastava N., Cefalu A.B., Noto D., Schonfeld G., Averna M., Srivastava R.A. The production of 85kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation. Biochem. Biophys. Res. Commun. 2010, 398:665-670.
22. Squier M.K., Miller A.C., Malkinson A.M., Cohen J.J. Calpain activation in apoptosis. J. Cell. Physiol. 1994, 159:229-237.
23. Atencio I.A., Ramachandra M., Shabram P., Demers G.W. Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ. Mol. Biol. J. Am. Assoc. Cancer. Res. 2000, 11:247.
24. Zhang P., Zhao Y., Zhu X., Sedwick D., Zhang X., Wang Z. Cross-talk between phospho-STAT3 and PLCgamma1 plays a critical role in colorectal tumorigenesis. Mol. Cancer Res. 2011, 9:1418-1428.